PROMOtion of VAccination in Canada (PromovaC Study)
Launched by UNIVERSITÉ DE SHERBROOKE · Dec 1, 2016
Trial Information
Current as of June 29, 2025
Completed
Keywords
ClinConnect Summary
OBJECTIVES
Main objective: To evaluate the impact of the motivational interviewing (MI) intervention on parents' intention to vaccinate their infant and their vaccine hesitancy (VH) score in a Pan-Canadian context. In order to explore differences in the intervention's impact according to cultural and organizational factors, all analysis will also be conducted at the level of each center.
Specific objectives:
1. To assess parents' intention to vaccinate their infant before the intervention and immediately after the intervention, globally and at each center level.
2. To assess parents' VH ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • All mothers of infants born in 1 of the 6 participating maternity wards.
- Exclusion Criteria:
- • Mothers aged \<18 years;
- • Mothers who do not speak English or French;
- • Any health situation of the newborn or the mother requiring acute care (i.e. if the newborn needs to be hospitalized in the neonatology unit or if the mother has an incompatible condition for an interview);
- • Mothers who have participated in one of the two studies evaluating the impact of the MI intervention in the Eastern Townships in 2009-2010 and in the province of Quebec in 2014-2015.
About Université De Sherbrooke
The Université de Sherbrooke is a leading research institution in Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. With a focus on interdisciplinary collaboration, the university actively engages in clinical trials to explore new therapeutic interventions and improve patient care. Its research team comprises experienced professionals dedicated to ensuring the highest ethical standards and scientific rigor in clinical research. The Université de Sherbrooke strives to translate research findings into practical solutions that enhance health outcomes and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, Nova Scotia, Canada
Toronto, Ontario, Canada
Surrey, British Columbia, Canada
Charlottetown, , Canada
Sherbrooke, Quebec, Canada
Vancouver, British Columbia, Canada
Charlottetown, Prince Edward Island, Canada
Patients applied
Trial Officials
Arnaud Gagneur, MD, PhD
Principal Investigator
Université de Sherbrooke
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials